Fagron NV (ARSUF)
PNK: ARSUF
· Real-Time Price · USD
20.03
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
Company Description
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients.
The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.
In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines.
Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy.
It has operations in Latin America, North America, Europe, the Middle East, and Africa.
The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015.
Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Fagron NV
| Country | BE |
| IPO Date | Feb 21, 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,828 |
| CEO | Rafael Padilla |
Contact Details
Address: Venecoweg 20A Nazareth, BE | |
| Website | https://www.fagron.com |
Stock Details
| Ticker Symbol | ARSUF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | BE0003874915 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Rafael Padilla | Chief Executive Officer & Executive Director |
| Karin de Jong | Chief Financial Officer & Executive Director |
| Vera Bakker | Chief Operating Officer |
| Johan Verlinden | Head of Legal, Mergers & Acquisitions |